欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/3174/002
药品名称
Hydrocortisone 20 mg Tablet
活性成分
hydrocortisone 20.0 mg
剂型
Tablet
上市许可持有人
Activase Pharmaceuticals Ltd, 11 Boumpoulinas, 1060 Nicosia, Cyprus
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Finland (FI)
Germany (DE)
Hydrocortisone 20 mg Tabletten
Netherlands (NL)
Sweden (SE)
United Kingdom (Northern Ireland) (XI)
Hydrocortisone 20 mg Tablet
Cyprus (CY)
许可日期
2017/05/08
最近更新日期
2024/01/03
药物ATC编码
H02AB09 hydrocortisone
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Labelling
|
DK_H_3174_001_002_IB_004 Hydrocortison Activase_ Common outer bottle carton clean
Date of last change:2024/09/06
Final PL
|
DK_H_3174_001_002_II_003 Hydrocortison Activase _ Common PL clean
Date of last change:2024/09/06
Final SPC
|
DK_H_3174_001_002_II_003 Hydrocortison Activase _ Common SPC 10 mg clean
Date of last change:2024/09/06
Final Product Information
|
DK_H_3174_001_002_II_003 Hydrocortison Activase _ Common SPC 20 mg clean
Date of last change:2024/09/06
PubAR
|
PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase